Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis.
Power JR, Alexandre J, Choudhary A, Ozbay B, Hayek SS, Asnani A, Tamura Y, Aras M, Cautela J, Thuny F, Gilstrap L, Arangalage D, Ewer S, Huang S, Deswal A, Palaskas NL, Finke D, Lehmann LH, Ederhy S, Moslehi J, Salem JE; International ICI-Myocarditis Registry.
Power JR, et al.
Arch Cardiovasc Dis. 2022 May;115(5):315-330. doi: 10.1016/j.acvd.2022.03.003. Epub 2022 Apr 27.
Arch Cardiovasc Dis. 2022.
PMID: 35595646
Free article.
At 30 days, myocarditis-related mortality was 20/124 (16.1%), and 28/124 (22.6%) met the composite endpoint. Patients who developed complete heart block (aHR by subdistribution hazards model [aHR(sh)] 3.29, 95% confidence interval [CI] 1.24-8.68; P=0.02) or life-threatenin …
At 30 days, myocarditis-related mortality was 20/124 (16.1%), and 28/124 (22.6%) met the composite endpoint. Patients who developed complete …